The CYP1A1 connection between enterolactone and breast cancer risk
Juana Hatwik, Ningthoujam Sonia, Anil Mukund Limaye
This study shows enterolactone reduces CYP1A1 mRNA expression in breast cancer cells by antagonizing AHR, while increasing CYP1A1 protein through ER, potentially lowering breast cancer risk.
Journal of Agriculture and Food Research · Oct 25, 2025Peer-reviewedCancer Biology